Tortus AI
NHS-validated ambient scribe with a hallucination-mitigation layer
Overview
Tortus AI is an ambient clinical assistant that transcribes consultations into EHR-ready notes, built as a registered Class I medical device with an independent safety-validation framework. It's deployed across NHS hospitals, GP practices, and ambulance services in the UK.
What you can produce with Tortus AI
- Ambient consultation transcription to EHR notes
- Class I registered medical device
- Hallucination-mitigation layer ("The Shell")
- Independent validation framework (CREOLA)
- DTAC-compliant deployment
- EHR write-back for NHS systems
ASEAN Perspective
Tortus AI in Southeast Asia
ASEAN-region availability and pricing notes coming soon. Drop the editorial team a note via /contact/ if you can supply local context (Singapore/Malaysia/Indonesia/Thailand/Vietnam).
Tortus treats clinical safety as the actual product, not a compliance afterthought: Class I medical device registration, a hallucination-mitigation layer it calls "The Shell," and an independent validation methodology (CREOLA) most ambient scribes don't bother building. That showed up in results — a GOSH-led trial across nine London NHS sites and over 17,000 patient encounters found a 23.5% increase in direct patient interaction time and an 8.2% reduction in appointment length, with one A&E department seeing 13.4% more patients seen per shift.
It's still an early-stage company: total disclosed funding is roughly $8.5 million across two seed rounds led by Khosla Ventures and Entrepreneur First, no Series A yet. Distribution is entirely NHS/enterprise procurement — there's no self-serve signup, no published pricing, and essentially zero footprint outside the UK, so ASEAN relevance today is closer to a reference architecture than a buyable product.
What people say
Tortus builds an ambient scribe the way a medical-device company would rather than a consumer software company: it's registered as a UK Class I medical device, runs a hallucination-detection layer it markets as "The Shell," and validates outputs against an internally developed framework called CREOLA rather than just trusting model output. That positioning is aimed squarely at NHS procurement teams who need to justify clinical-safety sign-off, not at individual clinicians shopping on price.
The strongest evidence for it isn't a review site — it's a real trial. NHS England backed a roughly £500,000, nine-site study led by Great Ormond Street Hospital's innovation unit covering over 17,000 patient encounters across hospitals, GP practices, mental health services, and ambulance teams. Results were framed as "transformative": a 23.5% increase in direct patient interaction time, an 8.2% reduction in overall appointment length, and at St George's University Hospitals' A&E department specifically, a 13.4% increase in patients seen per shift. Scaled across England's roughly 11,000 A&E clinicians, NHS modeling projected close to £176 million saved in documentation time and £658 million in unlocked capacity annually — numbers that come from the health system's own analysis, not Tortus marketing.
Following the trial, GOSH planned an autumn rollout of AI-scribe technology across outpatient settings, and Tortus has been referenced in the NHS's Ten Year Plan. Funding is comparatively modest for the traction it's getting: about $8.54 million across two seed rounds, most recently a £3.3 million round led by Khosla Ventures with Entrepreneur First and former NHS Chair Lord David Prior participating, no Series A announced as of mid-2026.
There's no public pricing, no self-serve trial, and the sales motion runs through NHS trust procurement or direct enterprise contact — appropriate for the market it's built for, but it means anyone outside UK healthcare evaluating Tortus is reading trial results and case studies rather than testing the product directly.
Summary of public user & expert reviews, compiled by RECATOOLS.
About this listing
This entry was compiled from publicly available data including Tortus AI's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Tortus AI unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Tortus AI directly →
Spotted something out of date? Suggest an update →
Tortus AI in the news
More in Productivity
